Treatment with anti-CD3 can significantly inhibit the proliferation of CD4+ T cells in the peripheral blood of patients with AS and, in mice, anti-CD3 treatment was observed to inhibit CD4+ T-cell activity in lung tissue and blood vessels, significantly reducing the level of asthma inflammation (31). Here, CD4 is linked to asthma.